Open AccessEfficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia
Author(s) -
Marcin Kubeczko,
Elżbieta Nowara,
Wojciech Spychałowicz,
Kamil Wdowiak,
Anna Bednarek,
Dobromiła Karwasiecka,
Jerzy Chudek,
Jerzy Wojnar
Publication year - 2016
Publication title -
postępy higieny i medycyny doświadczalnej
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.275
H-Index - 34
eISSN - 1732-2693
pISSN - 0032-5449
DOI - 10.5604/17322693.1202482
Subject(s) - medicine , cholecalciferol , vitamin d deficiency , gastroenterology , vitamin d and neurology , chronic lymphocytic leukemia , secondary hyperparathyroidism , hyperparathyroidism , endocrinology , leukemia , calcium , parathyroid hormone
Vitamin D (VD) deficiency in chronic lymphocytic leukemia (CLL) is associated with inferior prognosis, shorter time to treatment and worse overall survival. VD deficiency is the first potentially modifiable prognostic factor in CLL. Currently, however, there is a lack of studies concerning VD supplementation in CLL patients.